ID Name Structure References (top 5) Molecular Target(s)
1ID:692
ALPHA-BOSWELLIC ACID

Freqency:
in 2 ingredients:

  • 79
  • 417
  • in 70 recipes:

  • 4
  • 37
  • 38
  • 44
  • 45
  • 55
  • 57
  • 100
  • 101
  • 111
  • 122
  • 142
  • 143
  • 146
  • 172
  • 174
  • 181
  • 184
  • 194
  • 195
  • 199
  • 200
  • 203
  • 208
  • 229
  • 231
  • 236
  • 239
  • 249
  • 255
  • 257
  • 268
  • 276
  • 285
  • 289
  • 291
  • 293
  • 294
  • 303
  • 305
  • 313
  • 324
  • 339
  • 342
  • 352
  • 355
  • 361
  • 380
  • 381
  • 401
  • 412
  • 423
  • 430
  • 459
  • 461
  • 467
  • 469
  • 470
  • 472
  • 474
  • 475
  • 477
  • 483
  • 484
  • 491
  • 499
  • 502
  • 508
  • 513
  • 519

  • Properties
    C30H48O3    456.71





    1:  Syrovets T, Buchele B, Gedig E, Slupsky JR, Simmet T.
    Acetyl-boswellic acids are novel catalytic inhibitors of human topoisomerases I and IIalpha.
    Mol Pharmacol.    impact factor:   5.465
    2000;  58(1): 71-81

    2:  Hoernlein RF, Orlikowsky T, Zehrer C, Niethammer D, Sailer ER, Simmet T, Dannecker GE, Ammon HP.
    Acetyl-11-keto-beta-boswellic acid induces apoptosis in HL-60 and CCRF-CEM cells and inhibits topoisomerase I.
    J Pharmacol Exp Ther.    impact factor:   3.3
    1999;  288(2): 613-9

    3:  Safayhi H, Mack T, Sabieraj J, Anazodo MI, Subramanian LR, Ammon HP.
    Boswellic acids: novel, specific, nonredox inhibitors of 5-lipoxygenase.
    J Pharmacol Exp Ther.    impact factor:   3.3
    1992;  261(3): 1143-6

    4:  Schweizer S, Eichele K, Ammon HP, Safayhi H.
    3-Acetoxy group of genuine AKBA (acetyl-11-keto-beta-boswellic acid) is alpha-configurated.
    Planta Med.    impact factor:   1.438
    2000;  66(8): 781-2

    5:  [No authors listed]
    Monograph:Boswellia serrata.
    Altern Med Rev.    impact factor:   0
    1998;  3(4): 306-7

    BAS
    FAS
    TOPOISOMERASE II BETA
    TOPOISOMERASE II ALPHA
     
    Time used: 515 milliseconds.

    Webpage designed by Dr. Xueliang Fang, last updated on 3/10/2005